Company Overview
About AOA Dx
AOA Dx (formerly known under a different name) is a molecular diagnostics company developing novel diagnostic tests for earlier and more accurate disease detection, focusing on underserved testing gaps in clinical settings. The company applies innovative biomarker detection approaches to improve diagnostic accuracy in categories where current testing misses significant patient populations or delivers delayed results.
Business Model & Competitive Advantage
AOA Dx's technology platform leverages proprietary antibody-based detection methods and sample processing innovations that enable detection of low-abundance biomarkers in blood or other clinical samples — a key challenge in early disease detection where target molecule concentrations may be too low for conventional assays. The company's diagnostics are designed for integration into clinical laboratory workflows rather than point-of-care settings.
Competitive Landscape 2025–2026
In 2025, AOA Dx operates in the in-vitro diagnostics market, competing alongside established diagnostic companies including Roche Diagnostics, Abbott, Bio-Rad, and emerging molecular diagnostics startups for laboratory testing market share. The diagnostics industry has seen significant innovation investment as liquid biopsy technologies (detecting cancer from blood samples) and multiomics approaches expand the possibility space for non-invasive disease detection. AOA Dx's commercial strategy focuses on clinical validation studies to demonstrate diagnostic performance and building laboratory partnerships for commercialization of its novel testing panels.
Recent Activity
View all →Material Event filed 2026-09-29
Material Event filed 2026-09-25
Material Event filed 2026-07-28
Quarterly Report filed 2026-07-27
Material Event filed 2026-07-20
Study demonstrates that integrating lipids, metabolites, and proteins reveals coordinated molecular signatures missed by traditional single omic tests.
Key Differentiators
Strong Challenger
AOA Dx is an established challenger with significant market presence and competitive offerings in Healthcare.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Epic Systems
Epic Systems Corporation was founded in 1979 by Judith Faulkner and is headquartered in Verona, Wisconsin, remaining privately held with Faulkner as majority owner. The company develops large-scale el
athenahealth
athenahealth is a cloud-based electronic health records (EHR), medical billing, and practice management company founded in 1997 and headquartered in Watertown, Massachusetts. The company was built on
Pfizer
Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The compan
Moderna
Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stép
Amgen
Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologic
Veeva Systems
Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executiv
Compare AOA Dx with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from AOA Dx? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim AOA Dx Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention AOA Dx vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →